Attached files
| file | filename |
|---|---|
| S-1 - FORM S-1 - REGENERX BIOPHARMACEUTICALS INC | w78085sv1.htm |
| EX-4.2 - EX-4.2 - REGENERX BIOPHARMACEUTICALS INC | w78085exv4w2.htm |
| EX-3.2 - EX-3.2 - REGENERX BIOPHARMACEUTICALS INC | w78085exv3w2.htm |
| EX-3.4 - EX-3.4 - REGENERX BIOPHARMACEUTICALS INC | w78085exv3w4.htm |
| EX-4.4 - EX-4.4 - REGENERX BIOPHARMACEUTICALS INC | w78085exv4w4.htm |
| EX-3.1 - EX-3.1 - REGENERX BIOPHARMACEUTICALS INC | w78085exv3w1.htm |
| EX-3.3 - EX-3.3 - REGENERX BIOPHARMACEUTICALS INC | w78085exv3w3.htm |
| EX-4.3 - EX-4.3 - REGENERX BIOPHARMACEUTICALS INC | w78085exv4w3.htm |
| EX-4.1 - EX-4.1 - REGENERX BIOPHARMACEUTICALS INC | w78085exv4w1.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Form S-1 of our report dated
March 31, 2010, relating to the financial statements of RegeneRx Biopharmaceuticals, Inc., which
appear in such Registration Statement. We also consent to the reference to us under the heading
“Experts” in such Registration Statement.
/s/ Reznick Group, P.C.
Vienna, Virginia
April 16, 2010
April 16, 2010